rs769391314
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_022166.4(XYLT1):c.2560G>T(p.Glu854*) variant causes a stop gained, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000739 in 1,353,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_022166.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
- Desbuquois dysplasia 2Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Desbuquois dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- XYLT1-congenital disorder of glycosylationInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000550 AC: 1AN: 181890 AF XY: 0.0000105 show subpopulations
GnomAD4 exome AF: 7.39e-7 AC: 1AN: 1353524Hom.: 0 Cov.: 31 AF XY: 0.00000152 AC XY: 1AN XY: 659680 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at